Measured Review
Best for: people who want coaching-forward metabolic care and the choice of compounded or brand-name GLP-1s
Metabolic-health membership pairing GLP-1 treatment with 1:1 nutrition support and board-certified provider care. Compounded semaglutide and tirzepatide (from $79/mo microdose) plus brand-name Wegovy and Zepbound, with a separate $49/mo membership.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Measured is a solid telehealth option with balanced features and pricing.
Measured at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $79/mo (Weekly lower-dose semaglutide or tirzepatide (compounded).)
- What's included
- Medication · Consult · Coaching
- FDA status
- No FDA warning letter on record
How we scored Measured
Each dimension is scored algorithmically from Measured’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.3/10At $79/mo, Measured runs about 54% below the $170 median for GLP-1 providers.
Effectiveness25%
7.6/10Measured offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions.
User Experience15%
6.6/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
6.5/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-01).
Accessibility10%
5.3/10Measured's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
7.0/10Coaching/dietitian access included.
How we verified this Measured review
Last checked 2026-07-01- Confirmed current pricing across 5 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Measured offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Weekly lower-dose semaglutide or tirzepatide (compounded).
Compounded semaglutide.
Compounded tirzepatide.
Wegovy; cash-pay estimate, varies with coverage.
Zepbound; cash-pay estimate, varies with coverage.
Ready to get started?
Plans and promotions change often — check Measured's current pricing and active discounts before you decide.
What we like
- Membership includes 1:1 nutrition support and board-certified provider care
- Both compounded (from $79/mo microdose, $119 semaglutide, $229 tirzepatide) and brand-name Wegovy/Zepbound
- Insurance or cash-pay options for brand-name medications
- Oral option available (Wegovy pill); cancel-anytime membership
Watch-outs
- Membership ($49/mo) is billed separately on top of medication cost
- Compounded medications are not FDA-approved
- Compounding/dispensing pharmacies not individually named
- State availability not published
Is Measured worth it? Our verdict
Measured positions itself around one thing: people who want coaching-forward metabolic care and the choice of compounded or brand-name GLP-1s. It runs $79/month — toward the affordable end of the market. Coaching and follow-up are part of the package, not an upsell.
How much Measured actually costs
- Compounded semaglutide — $79/month
- Compounded semaglutide — $119/month
- Compounded tirzepatide — $229/month
- Brand-name semaglutide — $299/month
- Brand-name tirzepatide — $349/month
That puts Measured below the roughly $170 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Medications: what Measured prescribes
Measured prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. You can choose FDA-approved brand-name pens or lower-cost compounded versions — the compounded route is how the monthly price stays down, with the trade-off that compounded drugs aren't FDA-approved as finished products.
Who Measured is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost.
- want coaching and follow-up included, not sold separately.
Look elsewhere if you…
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Measured earns its place on the shortlist mainly on price: at $79/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
Ready to start with Measured?
Starting at $79/month. See current pricing and start your free consultation.
Alternatives to Measured
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Measured review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with Measured?
Starting at $79/month. See current pricing and start your free consultation.